StockWatch
·

KABRA DRUGS LTD. Q2 FY26 Results

KABRADGQ2 FY26 Results
Filing
MetricValue ( Cr)vs Q1 FY26
Revenue19.76176.4%
Total Income19.94178.3%
Expenditure17.74131.4%
PBT2.21541.1%
Net Profit1.84467.4%
OPM10.31%17.48pp
NPM9.21%16.19pp
EPS0.77266.7%
View full financials

Informational and educational content only. Not investment advice.